Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hunter

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Cancer Immunology, Immunotherapy : CII|April 27, 2021
COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockadeKyle Hansen, Sandeep Kumar, Kathryn Logronio, et al.
Journal of Medicinal Chemistry|July 31, 2014
Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)Li Tan, Tyzoon Nomanbhoy, Deepak Gurbani, et al.
Angewandte Chemie (International Ed. in English)|November 22, 2013
Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitorSang Min Lim, Kenneth D Westover, Scott B Ficarro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2025
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate CancerRahul R Aggarwal, Jacqueline Vuky, David VanderWeele, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 24, 2013
Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration studyNan Chen, Xiongfei Wu, Xiaoqiang Ding, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 7, 2025
Multi-Omics Reveal the Dysregulated Gut-Joint Axis in Knee Synovitis: Data from Two Osteoarthritis Studies in ChinaXiaoshuai Wang, Yi Liu, Ziying Sun, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 15, 2022
Characterization of the Immune Microenvironment in Inflammatory Breast Cancer Using Multiplex ImmunofluorescenceNahla M Badr, Jack L McMurray, Irini Danial, et al.
Annals of the Rheumatic Diseases|May 8, 2012
Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndromeJulia L Newton, James Frith, Danielle Powell, et al.
Annals of the Rheumatic Diseases|June 14, 2013
Health-related utility values of patients with primary Sjögren's syndrome and its predictorsDennis Lendrem, Sheryl Mitchell, Peter McMeekin, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USALudy R Carmola, Allison Dorothy Roebling, Dara Khosravi, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Cancer Immunology, Immunotherapy : CII|April 27, 2021
COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockadeKyle Hansen, Sandeep Kumar, Kathryn Logronio, et al.
Journal of Medicinal Chemistry|July 31, 2014
Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)Li Tan, Tyzoon Nomanbhoy, Deepak Gurbani, et al.
Angewandte Chemie (International Ed. in English)|November 22, 2013
Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitorSang Min Lim, Kenneth D Westover, Scott B Ficarro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2025
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate CancerRahul R Aggarwal, Jacqueline Vuky, David VanderWeele, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 24, 2013
Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration studyNan Chen, Xiongfei Wu, Xiaoqiang Ding, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 7, 2025
Multi-Omics Reveal the Dysregulated Gut-Joint Axis in Knee Synovitis: Data from Two Osteoarthritis Studies in ChinaXiaoshuai Wang, Yi Liu, Ziying Sun, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 15, 2022
Characterization of the Immune Microenvironment in Inflammatory Breast Cancer Using Multiplex ImmunofluorescenceNahla M Badr, Jack L McMurray, Irini Danial, et al.
Annals of the Rheumatic Diseases|May 8, 2012
Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndromeJulia L Newton, James Frith, Danielle Powell, et al.
Annals of the Rheumatic Diseases|June 14, 2013
Health-related utility values of patients with primary Sjögren's syndrome and its predictorsDennis Lendrem, Sheryl Mitchell, Peter McMeekin, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USALudy R Carmola, Allison Dorothy Roebling, Dara Khosravi, et al.
Pageof 16